❭ Action plans and policy papers ❭

Action plans and policy papers

Protocol: An anonymized GWAS to urgently query host genetic predisposition to severe COVID-19 (SARS-CoV-2 infection) lung disease (open as PDF)
Criteria for excellent research in KIT – report from work group (in Norwegian only) (open as PDF)
User involvement: possible models in KIT. Report from work group (in Norwegian only) (open as PDF)
Handlingsplan for forskning i KIT for 2021 (open as PDF)
Handlingsplan for forskning i KIT for 2022 (open as PDF)
Handlingsplan for forskning i KIT for 2023 (open as PDF)
 
Scroll to top

Home Div. of Surgery, Inflammatory Diseases and Transplantation

  • Research Institute of Internal Medicine
  • Research Management and the Research Committee
  • Action plans and policy papers
  • Strategisk protokollutvalg KIT
  • Annual reports
  • Research staff
  • Thematic areas

Recent publications

Li Y, Li X, Li X, Zhong Y, Ji Y, Yu D, Zhang M, Wen JG, Zhang H, Goscinski MA, Nesland JM, Suo Z (2025)
Retraction: PDHA1 gene knockout in prostate cancer cells results in metabolic reprogramming towards greater glutamine dependence
Oncotarget, 16, 790
DOI 10.18632/oncotarget.28777, PubMed 41201955

Reid S, Sandling JK, Pucholt P, Sayadi A, Frodlund M, Lerang K, Gunnarsson I, Jönsen A, Syvänen AC, Molberg Ø, Rantapää-Dahlqvist S, Rudin A, Sjöwall C, Svenungsson E, Bengtsson AA, Rönnblom L, Leonard D (2025)
Genetic risk factors and clinical manifestations of systemic lupus erythematosus: Large-scale analysis of genetic predisposition and disease subtypes
J Intern Med (in press)
DOI 10.1111/joim.70040, PubMed 41200769

Blomberg B, Myklebust NN, Oppegaard O, Tøndel C, Cox RJ, Iversen A, Lehmann ME, Sandvig A, Dahl TB, Valderhaug VD, Szodoray P, Wilhelmsen M, Kirsebom BE, Glambek M, Kaarbøe O, Aukrust P, Lie RT, Langeland N (2025)
Randomized trial of nirmatrelvir/ritonavir versus placebo for adults with acute COVID-19 to prevent long COVID: PanoramicNOR Trial
Trials, 26 (1), 477
DOI 10.1186/s13063-025-09226-6, PubMed 41199272

Assis DN, Hov JR (2025)
Phase 2 Clinical Trials in Primary Sclerosing Cholangitis: Making the Most of Every Opportunity?
J Hepatol (in press)
DOI 10.1016/j.jhep.2025.10.022, PubMed 41197906

More publications